Literature DB >> 11602336

Marked reduction of the Cu/Zn superoxide dismutase polypeptide in a case of familial amyotrophic lateral sclerosis with the homozygous mutation.

M Kato1, M Aoki, M Ohta, M Nagai, F Ishizaki, S Nakamura, Y Itoyama.   

Abstract

We identified a missense mutation of the Cu/Zn superoxide dismutase (SOD) gene (Leu126Ser) in a Japanese family with ALS that included a patient with the homozygous mutation. The content of the Cu/Zn SOD polypeptide in erythrocytes was markedly reduced in the case with the homozygous mutation compared to those with the heterozygous mutation. We speculated that this reduction of the mutant Cu/Zn SOD molecule might be related to the severe clinical phenotype of the case.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602336     DOI: 10.1016/s0304-3940(01)02212-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

Review 2.  Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy.

Authors:  Naoki Suzuki; Ayumi Nishiyama; Hitoshi Warita; Masashi Aoki
Journal:  J Hum Genet       Date:  2022-06-13       Impact factor: 3.172

Review 3.  Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene.

Authors:  Peter M Andersen
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

4.  An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1.

Authors:  Mercedes Prudencio; Armando Durazo; Julian P Whitelegge; David R Borchelt
Journal:  Hum Mol Genet       Date:  2010-09-24       Impact factor: 6.150

5.  The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tension.

Authors:  Isil Keskin; Elin Forsgren; Manuela Lehmann; Peter M Andersen; Thomas Brännström; Dale J Lange; Matthis Synofzik; Ulrika Nordström; Per Zetterström; Stefan L Marklund; Jonathan D Gilthorpe
Journal:  Acta Neuropathol       Date:  2019-03-12       Impact factor: 17.088

6.  Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutation.

Authors:  Masanori Sawamura; Keiko Imamura; Rie Hikawa; Takako Enami; Ayako Nagahashi; Hodaka Yamakado; Hidenori Ichijo; Takao Fujisawa; Hirofumi Yamashita; Sumio Minamiyama; Misako Kaido; Hiromi Wada; Makoto Urushitani; Haruhisa Inoue; Naohiro Egawa; Ryosuke Takahashi
Journal:  Sci Rep       Date:  2022-07-25       Impact factor: 4.996

7.  Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.

Authors:  Mercedes Prudencio; P John Hart; David R Borchelt; Peter M Andersen
Journal:  Hum Mol Genet       Date:  2009-05-30       Impact factor: 6.150

Review 8.  Is SOD1 loss of function involved in amyotrophic lateral sclerosis?

Authors:  Rachele A Saccon; Rosie K A Bunton-Stasyshyn; Elizabeth M C Fisher; Pietro Fratta
Journal:  Brain       Date:  2013-05-17       Impact factor: 13.501

9.  Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia.

Authors:  Pietro Fratta; Mark Poulter; Tammaryn Lashley; Jonathan D Rohrer; James M Polke; Jon Beck; Natalie Ryan; Davina Hensman; Sarah Mizielinska; Adrian J Waite; Mang-Ching Lai; Tania F Gendron; Leonard Petrucelli; Elizabeth M C Fisher; Tamas Revesz; Jason D Warren; John Collinge; Adrian M Isaacs; Simon Mead
Journal:  Acta Neuropathol       Date:  2013-07-02       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.